Startup | November 29, 2021
ZenOnco.io raises US $ 1.4 mn in seed funding
The funds will be used to scale up existing operations and launch new products
The funds will be used to scale up existing operations and launch new products
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
Featuring identity verification using artificial intelligence (AI), LabPort was designed to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments
Nelarabine is in a class of medications called antimetabolites
The union health ministry notifies the protocol and this move will also help in organ donation
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Gini Health works in the domain of personalised healthcare
Acute therapies continue to report strong growth compared to chronic ones.
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
Subscribe To Our Newsletter & Stay Updated
